BRPI0912161A2 - composição farmacêutica na forma de um tablete - Google Patents
composição farmacêutica na forma de um tableteInfo
- Publication number
- BRPI0912161A2 BRPI0912161A2 BRPI0912161A BRPI0912161A BRPI0912161A2 BR PI0912161 A2 BRPI0912161 A2 BR PI0912161A2 BR PI0912161 A BRPI0912161 A BR PI0912161A BR PI0912161 A BRPI0912161 A BR PI0912161A BR PI0912161 A2 BRPI0912161 A2 BR PI0912161A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Psychology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08009919 | 2008-05-30 | ||
| PCT/EP2009/056570 WO2009144286A1 (en) | 2008-05-30 | 2009-05-28 | Pharmaceutical compositions comprising brivaracetam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0912161A2 true BRPI0912161A2 (pt) | 2015-10-06 |
Family
ID=39714168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0912161A BRPI0912161A2 (pt) | 2008-05-30 | 2009-05-28 | composição farmacêutica na forma de um tablete |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8435564B2 (pt) |
| EP (1) | EP2285357B8 (pt) |
| JP (1) | JP5553452B2 (pt) |
| CN (1) | CN102046153B (pt) |
| BR (1) | BRPI0912161A2 (pt) |
| CA (1) | CA2722093C (pt) |
| DK (1) | DK2285357T3 (pt) |
| ES (1) | ES2465478T3 (pt) |
| PL (1) | PL2285357T3 (pt) |
| WO (1) | WO2009144286A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011135430A1 (en) | 2010-04-29 | 2011-11-03 | Lupin Limited | Controlled release pharmaceutical compositions of brivaracetam |
| WO2012040082A2 (en) * | 2010-09-21 | 2012-03-29 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
| MA43532A (fr) | 2015-12-30 | 2018-11-07 | Adamas Pharmaceuticals Inc | Méthodes et compositions destinés au traitement de troubles liés à des crises épileptiques |
| WO2018224680A1 (en) * | 2017-06-09 | 2018-12-13 | Bimeda Research & Development Limited | Intramammary veterinary composition |
| JP7335870B2 (ja) * | 2017-08-31 | 2023-08-30 | パーデュー、ファーマ、リミテッド、パートナーシップ | 医薬剤形 |
| CN109833300A (zh) * | 2017-11-28 | 2019-06-04 | 浙江京新药业股份有限公司 | 一种抗癫痫药物口服组合物及其制备方法 |
| CN110638743B (zh) * | 2019-10-25 | 2023-03-28 | 乐普制药科技有限公司 | 一种含布立西坦的组合物 |
| CN111407738A (zh) * | 2020-04-03 | 2020-07-14 | 江苏艾立康药业股份有限公司 | 一种布立西坦控释制剂及其制备方法 |
| WO2022007758A1 (zh) | 2020-07-09 | 2022-01-13 | 上海博志研新药物技术有限公司 | 一种布瓦西坦药物组合物、其制备方法及应用 |
| US20240148693A1 (en) * | 2021-03-17 | 2024-05-09 | Changsha Jingyi Pharmaceutical Technology Co., Ltd | Composition, preparation method therefor, and use thereof |
| CN115192572B (zh) * | 2021-04-08 | 2023-09-19 | 成都同道慧宜生物医药科技有限公司 | 布立西坦药剂、其制备方法和应用 |
| CN115721624A (zh) * | 2021-08-25 | 2023-03-03 | 北京海美源医药科技有限公司 | 一种布立西坦药物组合物及其制备方法和其应用 |
| US12133918B2 (en) | 2021-10-01 | 2024-11-05 | Griffin Gamma, Llc | Partially pre-gelatinized cassava starch as pharmaceutical excipient |
| CN118450889A (zh) * | 2021-12-27 | 2024-08-06 | 广东东阳光药业股份有限公司 | 布立西坦片剂及其制备方法 |
| CN118416004A (zh) | 2023-02-02 | 2024-08-02 | 泰州越洋医药开发有限公司 | 一种布立西坦双释三层片及其制备方法 |
| EP4491176A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | A film coated tablet comprising brivaracetam |
| EP4491177A1 (en) * | 2023-07-14 | 2025-01-15 | Sanovel Ilac Sanayi ve Ticaret A.S. | Film coated tablets of brivaracetam |
| EP4559457A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet composition of brivaracetam |
| EP4559456A1 (en) * | 2023-11-22 | 2025-05-28 | Sanovel Ilac Sanayi ve Ticaret A.S. | A modified release tablet of brivaracetam |
| TR2023015501A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet |
| TR2023015500A1 (tr) * | 2023-11-22 | 2025-06-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Bri̇varasetam i̇çeren deği̇şti̇ri̇lmi̇ş salimli bi̇r tablet kompozi̇syonu |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9518953D0 (en) * | 1995-09-15 | 1995-11-15 | Pfizer Ltd | Pharmaceutical formulations |
| RU2346996C2 (ru) | 2004-06-29 | 2009-02-20 | ЮРОПИЭН НИКЕЛЬ ПиЭлСи | Усовершенствованное выщелачивание основных металлов |
| EA014249B1 (ru) * | 2005-01-27 | 2010-10-29 | Алембик Лимитед | Формуляция леветирацетама длительного высвобождения |
| WO2006090275A1 (en) * | 2005-02-24 | 2006-08-31 | Pfizer Limited | Treatment of incontinence |
| KR101280096B1 (ko) | 2005-06-29 | 2013-06-28 | 컴퓨메딕스 리미티드 | 전도성 브리지를 포함하는 센서 어셈블리 |
| TW200735878A (en) * | 2005-11-18 | 2007-10-01 | Astrazeneca Ab | Pharmaceutical compositions |
| DK1954241T3 (da) * | 2005-11-28 | 2012-06-18 | Orexigen Therapeutics Inc | Zonisamid-formulering med vedvarende frigivelse |
| US8338621B2 (en) | 2005-12-21 | 2012-12-25 | Ucb S.A. | Process for the preparation of 2-oxo-1-pyrrolidine derivatives |
| AU2006335344A1 (en) * | 2006-01-11 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Controlled release formulation of divalproic acid and its derivatives |
| ES2444009T3 (es) * | 2006-06-08 | 2014-02-21 | Ucb Pharma, S.A. | Co-cristales de pirrolidinonas |
| JP2006335771A (ja) * | 2006-09-22 | 2006-12-14 | Takeda Chem Ind Ltd | 徐放性製剤およびその製造方法 |
| EA200900531A1 (ru) * | 2006-10-12 | 2009-12-30 | Эббот Лаборейторис | Фармацевтические составы |
-
2009
- 2009-05-28 JP JP2011511013A patent/JP5553452B2/ja active Active
- 2009-05-28 PL PL09753941T patent/PL2285357T3/pl unknown
- 2009-05-28 CA CA2722093A patent/CA2722093C/en active Active
- 2009-05-28 US US12/993,704 patent/US8435564B2/en active Active
- 2009-05-28 WO PCT/EP2009/056570 patent/WO2009144286A1/en not_active Ceased
- 2009-05-28 DK DK09753941.5T patent/DK2285357T3/da active
- 2009-05-28 BR BRPI0912161A patent/BRPI0912161A2/pt not_active IP Right Cessation
- 2009-05-28 ES ES09753941.5T patent/ES2465478T3/es active Active
- 2009-05-28 CN CN200980120221.XA patent/CN102046153B/zh active Active
- 2009-05-28 EP EP09753941.5A patent/EP2285357B8/en not_active Revoked
Also Published As
| Publication number | Publication date |
|---|---|
| EP2285357A1 (en) | 2011-02-23 |
| CA2722093C (en) | 2015-04-28 |
| CN102046153A (zh) | 2011-05-04 |
| JP5553452B2 (ja) | 2014-07-16 |
| PL2285357T3 (pl) | 2014-08-29 |
| HK1153141A1 (en) | 2012-03-23 |
| ES2465478T8 (es) | 2014-08-22 |
| ES2465478T3 (es) | 2014-06-05 |
| US8435564B2 (en) | 2013-05-07 |
| DK2285357T3 (da) | 2014-06-02 |
| JP2011521927A (ja) | 2011-07-28 |
| EP2285357B1 (en) | 2014-05-07 |
| US20110091547A1 (en) | 2011-04-21 |
| CA2722093A1 (en) | 2009-12-03 |
| WO2009144286A1 (en) | 2009-12-03 |
| CN102046153B (zh) | 2015-06-17 |
| EP2285357B8 (en) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0912161A2 (pt) | composição farmacêutica na forma de um tablete | |
| CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI1012004A2 (pt) | "forma farmacêutica" | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| EP2419097A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BRPI0822398B8 (pt) | forma sólida cristalina e composição farmacêutica que a compreende | |
| IL207128A0 (en) | Pharmaceutical dosage form | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| ATE493119T1 (de) | Pharmazeutische zusammensetzung | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| BRPI0910901A2 (pt) | composição farmacêutica com bisfosfonato | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| EP2193795A4 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST | |
| ZA200903858B (en) | Pharmaceutical dosage form | |
| BRPI0807882A2 (pt) | Forma de dosagem | |
| BRPI0812964A2 (pt) | Forma de dosagem farmacêutica oral sólida | |
| BR112012003149A2 (pt) | composição farmacêutica | |
| BRPI0912171A2 (pt) | composição farmacêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2517 DE 02-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |